French Loi Sapin extended to digital media
In 1993, the French government introduced a new anti-corruption law, the Loi Sapin, designed to introduce transparency into media buying.
View ArticleLike marriage, great client – agency relationships need constant vigilance
Two years ago, we published an article on the secrets of great partnerships between advertisers and media agencies. Since then, plenty has changed in the dynamics of this critical relationship, so now...
View ArticleCMO research heralds ‘data dawn’ in Europe
What keeps the modern/today’s CMOs awake at night? What resources and skills do they need to enable them to thrive in the always-on world of digital and social media? What talent and external...
View ArticleRick Rule: Market Chaos Creates Opportunities
>>Interview With Rick Rule (MP3) I had the chance to visit once again with Rick Rule, Chairman of Sprott US Holdings. It was a great conversation, focusing on the state of metals and mining, a...
View ArticleOsisko makes a move for Brett Resources
Osisko is already in the process of bringing its big shallow low grade Canadian Malartic gold project to production in an open-pit operation that it estimates will produce 591,000 ounces of gold per year
View ArticleBarrick Gold remains bullish on gold price, affording higher dividend and...
A positive gold price outlook, combined with a strong financial position and impressive cash flow has allowed Barrick to both invest in its project pipeline and now pay a quarterly dividend.
View ArticleValiant Petroleum hit by news of dry Viola North exploration well
Shares in Valiant Petroleum PLC (LON:VPP) fell after the company reported its operated Viola North exploration well in the Central North Sea will be plugged and abandoned as a dry hole.
View ArticleTargeted Microwave Solutions gaining traction in three world territories
This has been an exciting year for Targeted Microwave Solutions (CNSX:TMS), with one achievement coming on the heels of another. One major milestone came in late July in the form of an Indonesian...
View ArticleGlobal Cobalt spins off its North American assets in a newly formed company
Global Cobalt (CVE:GCO) (OTCBB:GLBCF) has split its Russian and North American operations forming two separately listed companies as part of a major reorganization. The spinout company, New Energy...
View ArticleGlobal Cobalt and IMHL lock up spinoff agreement
Global Cobalt (TSX-V:GCO) (OTCBB:GLBCF) and its largest shareholder, Imperial Mining Holding Limited ("IMHL") have agreed to terms on a binding agreement to spin off certain North American mineral...
View ArticleGlobal Cobalt will raise $250,000 to complete spin-out plan
Global Cobalt (CVE:GCO) (OTCBB:GLBCF) will raise C$250,000 through a non-brokered private placement of up to 5,000,000 units of the Company at a price of $0.05/each. The company plans to use funds to...
View ArticleM Pharmaceutial completes acquisition of RC Global Capital and exclusive...
M Pharmaceutical (CSE:MQ) said it has closed its previously announced acquisition of RX Global Capital Inc. to acquire the intellectual property associated with temporary controllable pseudobezoars, a...
View ArticleM Pharmaceutical expands portfolio of diabetes and obesity fighting devices
M Pharmaceutical (CSE:MQ) has agreed to buy Trimtec Biomedical, because of its proprietary Gastric Stimulator technology, in order to expand its family of biomedical devices targeting obesity and...
View ArticleTargeted Microwave Solutions harnesses microwave energy to revolutionise...
For Targeted Microwave Solutions Inc (CSE:TMS), unique technology and a strong corporate profile is clearly resonating with investors...
View ArticleJames Turk: "This Has Never Happened Before In History"
>>Interview With James Turk (MP3) I had the chance to sit down recently with James Turk, Director of Gold Money Inc. It was a fascinating conversation of monetary history and gold, with the...
View ArticleXenetic Biosciences gets rave US reviews after completing stateside move
Xenetic Biosciences is AIMing to succeed where Robbie Williams and Marks & Spencer have failed before it – by becoming a hit on both sides of the Atlantic. The drug developer, which delisted from...
View ArticleXenetic Biosciences confirms research continues with Baxalta
Xenetic Biosciences (OTC:XBIO) told investors that it is continuing contracts and arrangements previously entered into with Baxter Healthcare (NYSE:BAX) which have now been transferred to spin-out...
View ArticleXenetic starts 3rd cohort of mid-stage trials on Anemia drug
Xenetic Biosciences (OTCMKTS:XBIO), a clinical-stage biopharmaceutical company, started the third Cohort of its mid-stage dose-escalation study with its lead drug candidate ErepoXen for the treatment...
View ArticleMarc Faber: “As Global Economic Conditions Become Worse—Central Banks Will...
>>Interview With Marc Faber (MP3) I had the chance once again to sit down with Marc Faber, publisher of the Gloom, Boom & Doom Report. It was a fascinating conversation, as Marc’s residency...
View Article/pic9814888.png)
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-4-2026-09-17-19-01-31.png)
